Concepedia

Indhumathy Subramaniyan

IS

Statistics

Publications

3

Citations

155

H-Index

3

Active since

2018

Affiliations

Texas Tech University Health Sciences Center(Current)

The University of Texas Southwestern Medical Center

Texas Tech University

Indhumathy Subramaniyan is an author at Texas Tech University Health Sciences Center specializing in cancer pharmacology, pharmacology, and oncology.

ORCID

Publications per year

2018–2021

3

Publications

3

Phase 1 study of ARQ 761, a β-lapachone analogue that promotes NQO1-mediated programmed cancer cell necrosis

David E. Gerber, Muhammad Shaalan Beg, Farjana Fattah et al. · British Journal of Cancer · 2018 · 97 citations · Full text

, , +12

Itraconazole Exerts Its Antitumor Effect in Esophageal Cancer By Suppressing the HER2/AKT Signaling Pathway

Wei Zhang, Ankur S. Bhagwath, Zeeshan Ramzan et al. · Molecular Cancer Therapeutics · 2021 · 31 citations · Full text

, , +17

Concentration-dependent Early Antivascular and Antitumor Effects of Itraconazole in Non–Small Cell Lung Cancer

David E. Gerber, William C. Putnam, Farjana Fattah et al. · Clinical Cancer Research · 2020 · 27 citations · Full text

, , +16

1–3 of 3